Abstract
Hearing loss is the most common birth defect and sensorineural disorder in humans. Hearing loss can be syndromic or nonsyndromic and can be further divided based on mode of inheritance. With over 100 genes responsible for the etiology of hearing loss, Sanger sequencing, being a traditional gene-by-gene approach, has become an unfavorable strategy in terms of cost and time. Next-generation sequencing technology offers the advantage of sequencing multiple genes in parallel with lower cost and higher time-efficiency and has quickly become a fundamental tool for targeted panel-based hearing loss diagnostics. In this chapter, we discuss the application of next-generation sequencing to hearing loss, address successes and challenges of the approach, examine the current role of whole exome sequencing and comment on the future of whole genome sequencing. We conclude that the application of next generation sequencing will tremendously broaden our knowledge of hearing loss; the outcome of which includes rapid and accurate diagnosis that would result in an earlier and more effective intervention.
An erratum to this chapter can be found at http://dx.doi.org/10.1007/978-3-319-56418-0_17
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Atik, T., Bademci, G., Diaz-Horta, O., et al.: Whole-exome sequencing and its impact in hereditary hearing loss. Genet. Res. 97, e4 (2015). doi:10.1017/S001667231500004X
Azaiez, H., Booth, K.T., Bu, F., et al.: TBC1D24 mutation causes autosomal-dominant nonsyndromic hearing loss. Hum. Mutat. 35, 819–823 (2014). doi:10.1002/humu.22557
Bamshad, M.J., Ng, S.B., Bigham, A.W., et al.: Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet. 12, 745–755 (2011). doi:10.1038/nrg3031
Behlouli, A., Bonnet, C., Abdi, S., et al.: EPS8, encoding an actin-binding protein of cochlear hair cell stereocilia, is a new causal gene for autosomal recessive profound deafness. Orphanet J. Rare Dis. 9, 55 (2014). doi:10.1186/1750-1172-9-55
Bonnet, C., Grati, M., Marlin, S., et al.: Complete exon sequencing of all known Usher syndrome genes greatly improves molecular diagnosis. Orphanet J. Rare Dis. 6, 21 (2011). doi:10.1186/1750-1172-6-21
Brownstein, Z., Avraham, K.B.: Deafness genes in Israel: implications for diagnostics in the clinic. Pediatr. Res. 66, 128–134 (2009). doi:10.1203/PDR.0b013e3181aabd7f
Brownstein, Z., Friedman, L.M., Shahin, H., et al.: Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families. Genome Biol. 12, R89 (2011). doi:10.1186/gb-2011-12-9-r89
Clark, M.J., Chen, R., Lam, H.Y.K., et al.: Performance comparison of exome DNA sequencing technologies. Nat. Biotechnol. 29, 908–914 (2011). doi:10.1038/nbt.1975
Cohen, M., Phillips 3rd, J.A.: Genetic approach to evaluation of hearing loss. Otolaryngol. Clin. N. Am. 45, 25–39 (2012). doi:10.1016/j.otc.2011.08.015
De Keulenaer, S., Hellemans, J., Lefever, S., et al.: Molecular diagnostics for congenital hearing loss including 15 deafness genes using a next generation sequencing platform. BMC Med. Genet. 5, 17 (2012). doi:10.1186/1755-8794-5-17
Dewey, F.E., Grove, M.E., Pan, C., et al.: Clinical interpretation and implications of whole-genome sequencing. JAMA. 311, 1035–1045 (2014). doi:10.1001/jama.2014.1717
Diaz-Horta, O., Duman, D., Foster, J., et al.: Whole-exome sequencing efficiently detects rare mutations in autosomal recessive nonsyndromic hearing loss. PLoS One. 7, e50628 (2012). doi:10.1371/journal.pone.0050628
Gao, X., Dai, P.: Impact of next-generation sequencing on molecular diagnosis of inherited non-syndromic hearing loss. J. Otolaryngol. 9, 122–125 (2014). doi:10.1016/j.joto.2014.11.003
Hilgert, N., Smith, R.J.H., Van Camp, G.: Forty-six genes causing nonsyndromic hearing impairment: which ones should be analyzed in DNA diagnostics? Mutat. Res. 681, 189–196 (2009). doi:10.1016/j.mrrev.2008.08.002
Kochhar, A., Hildebrand, M.S., Smith, R.J.H.: Clinical aspects of hereditary hearing loss. Genet. Med. 9, 393–408 (2007). doi:10.1097/GIM.0b013e3180980bd0
Licastro, D., Mutarelli, M., Peluso, I., et al.: Molecular diagnosis of Usher syndrome: application of two different next generation sequencing-based procedures. PLoS One. 7, e43799 (2012). doi:10.1371/journal.pone.0043799
Mamanova, L., Coffey, A.J., Scott, C.E., et al.: Target-enrichment strategies for next-generation sequencing. Nat. Methods. 7, 111–118 (2010). doi:10.1038/nmeth.1419
Morton, C.C., Nance, W.E.: Newborn hearing screening--a silent revolution. N. Engl. J. Med. 354, 2151–2164 (2006). doi:10.1056/NEJMra050700
Raviv, D., Dror, A.A., Avraham, K.B.: Hearing loss: a common disorder caused by many rare alleles. Ann. N. Y. Acad. Sci. 1214, 168–179 (2010). doi:10.1111/j.1749-6632.2010.05868.x
Rehman, A.U., Morell, R.J., Belyantseva, I.A., et al.: Targeted capture and next-generation sequencing identifies C9orf75, encoding taperin, as the mutated gene in nonsyndromic deafness DFNB79. Am. J. Hum. Genet. 86, 378–388 (2010). doi:10.1016/j.ajhg.2010.01.030
Rehm, H.L., Bale, S.J., Bayrak-Toydemir, P., et al.: Working Group of the American College of Medical Genetics and Genomics Laboratory Quality Assurance Commitee: ACMG clinical laboratory standards for next-generation sequencing. Genet. Med. 15, 733–747 (2013). doi:10.1038/gim.2013.92
Schrauwen, I., Sommen, M., Corneveaux, J.J., et al.: A sensitive and specific diagnostic test for hearing loss using a microdroplet PCR-based approach and next generation sequencing. Am. J. Med. Genet. A. 161A, 145–152 (2013). doi:10.1002/ajmg.a.35737
Shearer, A.E., DeLuca, A.P., Hildebrand, M.S., et al.: Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc. Natl. Acad. Sci. U. S. A. 107, 21104–21109 (2010). doi:10.1073/pnas.1012989107
Sivakumaran, T.A., Husami, A., Kissell, D., et al.: Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss. Otolaryngol Head Neck Surg. 148(6), 1007–1016 (2013). doi:10.1177/0194599813482294
Smith, R.J., Shearer, A.E., Hildebrand, M.S., Van Camp, G.: Deafness and hereditary hearing loss overview. In: Pagon, R.A., Bird, T.D., Dolan, C.R., et al. (eds.) GeneReviews™. University of Washington, Seattle (1993)
Teer, J.K., Mullikin, J.C.: Exome sequencing: the sweet spot before whole genomes. Hum. Mol. Genet. 19, R145–R151 (2010). doi:10.1093/hmg/ddq333
Tewhey, R., Warner, J.B., Nakano, M., et al.: Microdroplet-based PCR enrichment for large-scale targeted sequencing. Nat. Biotechnol. 27, 1025–1031 (2009). doi:10.1038/nbt.1583
Van Camp, G., Willems, P.J., Smith, R.J.: Nonsyndromic hearing impairment: unparalleled heterogeneity. Am. J. Hum. Genet. 60, 758–764 (1997)
Vandebona, H., Mitchell, P., Manwaring, N., et al.: Prevalence of Mitochondrial 1555A→G Mutation in Adults of European Descent. N. Engl. J. Med. 360, 642–644 (2009). doi:10.1056/NEJMc0806397
Vona, B., Müller, T., Nanda, I., et al.: Targeted next-generation sequencing of deafness genes in hearing-impaired individuals uncovers informative mutations. Genitourin. Med. 16, 945–953 (2014). doi:10.1038/gim.2014.65
Xing, G., Yao, J., Wu, B., et al.: Identification of OSBPL2 as a novel candidate gene for progressive nonsyndromic hearing loss by whole-exome sequencing. Genitourin. Med. 17, 210–218 (2015). doi:10.1038/gim.2014.90
Yan, D., Zhu, Y., Walsh, T., et al.: Mutation of the ATP-gated P2X(2) receptor leads to progressive hearing loss and increased susceptibility to noise. Proc. Natl. Acad. Sci. U. S. A. 110, 2228–2233 (2013). doi:10.1073/pnas.1222285110
Zbar, R.I., Ramesh, A., Srisailapathy, C.R., et al.: Passage to India: the search for genes causing autosomal recessive nonsyndromic hearing loss. Otolaryngol. Head Neck Surg. 118, 333–337 (1998)
Zhao, Y., Zhao, F., Zong, L., et al.: Exome sequencing and linkage analysis identified tenascin-C (TNC) as a novel causative gene in nonsyndromic hearing loss. PLoS One. 8, e69549 (2013). doi:10.1371/journal.pone.0069549
Zheng, J., Miller, K.K., Yang, T., et al.: Carcinoembryonic antigen-related cell adhesion molecule 16 interacts with alpha-tectorin and is mutated in autosomal dominant hearing loss (DFNA4). Proc. Natl. Acad. Sci. U. S. A. 108, 4218–4223 (2011). doi:10.1073/pnas.1005842108
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Wang, X., Dyer, L., Zhang, K., Greinwald, J., Alexander Valencia, C. (2017). Application of Next-Generation Sequencing to Hearing Loss. In: Wong, LJ. (eds) Next Generation Sequencing Based Clinical Molecular Diagnosis of Human Genetic Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-56418-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-56418-0_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56416-6
Online ISBN: 978-3-319-56418-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)